ID: ALA3088216

Max Phase: Preclinical

Molecular Formula: C23H27NO2

Molecular Weight: 349.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1OC2(CCCCC2)CN(Cc2ccccc2)[C@H]1Cc1ccccc1

Standard InChI:  InChI=1S/C23H27NO2/c25-22-21(16-19-10-4-1-5-11-19)24(17-20-12-6-2-7-13-20)18-23(26-22)14-8-3-9-15-23/h1-2,4-7,10-13,21H,3,8-9,14-18H2/t21-/m0/s1

Standard InChI Key:  LAILGRMGOOTHNT-NRFANRHFSA-N

Associated Targets(non-human)

Testosterone 17-beta-dehydrogenase 3 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 349.47Molecular Weight (Monoisotopic): 349.2042AlogP: 4.36#Rotatable Bonds: 4
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.94CX LogP: 5.32CX LogD: 5.19
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.77Np Likeness Score: 0.20

References

1. Djigoué GB, Kenmogne LC, Roy J, Poirier D..  (2013)  Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.,  23  (23): [PMID:24144853] [10.1016/j.bmcl.2013.09.072]
2. Djigoué GB, Kenmogne LC, Roy J, Maltais R, Poirier D..  (2015)  Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.,  23  (17): [PMID:26277760] [10.1016/j.bmc.2015.07.049]

Source